GlassScriptPhysician profile
Nishant Sharma
NPI 1740779768
$1,665.43
in general payments reported to CMS, 2019-2025
21 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $122 · 2021: $19.34 · 2023: $42.33 · 2024: $218 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $974 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $973.98 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $356.48 | 2019-2020 | |
| Glaxosmithkline, LLC. | $225.90 | 2025 | Nucala, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.00 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $170.17 | 2025 | Tezspire, Fasenra, Breztri |
| Pfizer INC. | $111.64 | 2019 | |
| Genzyme Corporation | $107.67 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $80.67 | 2024-2025 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Insmed, INC. | $49.87 | 2024-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $42.33 | 2023 | Recarbrio, Zerbaxa |
| Mylan Specialty L.P. | $37.48 | 2024 | Yupelri |
| United Therapeutics Corporation | $26.55 | 2025 | Tyvaso |
| Ethicon INC. | $24.79 | 2025 | Monarch Platform |
| Mallinckrodt Hospital Products INC. | $24.77 | 2025 | Acthar |
| Amgen INC. | $21.76 | 2025 | Tezspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $19.43 | 2025 | Yupelri |
| Ani Pharmaceuticals, INC. | $19.42 | 2024 | Purified Cortrophin Gel |
| Baxter Healthcare | $16.10 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $15.59 | 2025 | Vest Therapy Und |
| Verona Pharma, INC. | $15.11 | 2025 | Ohtuvayre |
| Intuitive Surgical, INC. | $4.71 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nishant Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.